MPS VI Recruiting Phase 1 / 2 Trials for Vosoritide (DB11928)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0053627 (MPS VI) | Recruiting | 1 / 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT05845749 | Safety and Efficacy of Voxzogo for Growth Deficits in MPS IVA and VI | Other |